One in two cancer patients is significantly distressed: Prevalence and indicators of distress

Psycho-Oncology

Volumn 27, Issue 1, 2018, Pages 75-82

  Mehnert, A ^a   Hartung, T J ^a   Friedrich, M ^a   Vehling, S ^b   Brahler E ^a,c   Harter M ^b   Keller, M ^d   Schulz, H ^b   Wegscheider, K ^b   Weis, J ^e   Koch, U ^b   Faller, H ^f  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

^f UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

cancer; distress; fatigue; National Comprehensive Cancer Network distress thermometer; oncology; psychosocial

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SCREENING; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DISTRESS SYNDROME; FATIGUE; FEMALE; GERMANY; HUMAN; INDIGESTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NATIONAL COMPREHENSIVE CANCER NETWORK DISTRESS THERMOMETER; PREVALENCE; PROBLEM IDENTIFICATION; PSYCHOLOGICAL DISTRESS ASSESSMENT; RATING SCALE; SADNESS; SLEEP DISORDER; COMPLICATION; DEPRESSION; EMOTION; HEALTH SURVEY; MASS SCREENING; MENTAL STRESS; MIDDLE AGED; NEOPLASM; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; AGED; DEPRESSION; EMOTIONS; FATIGUE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; STRESS, PSYCHOLOGICAL;

EID: 85040807292     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.4464     Document Type: Article

References (52)

1. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-Oncology. 2001;10(1):19-28.
2. Brintzenhofe-Szoc KM, Levin TT, Li Y, Kissane DW, Zabora JR. Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type. Psychosomatics. 2009;50(4):383-391.
3. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-174.
4. Vehling S, Koch U, Ladehoff N, et al. Prevalence of affective and anxiety disorders in cancer: systematic literature review and meta-analysis. Psychother Psychosom Med Psychol. 2012;62(7):249-258.
5. Mehnert A, Vehling S, Scheffold K, et al. Prevalence of adjustment disorder, acute and posttraumatic stress disorders as well as somatoform disorders in cancer patients-a systematic literature review. Psychother Psychosom Med Psychol. 2013;63(12):466-472.
6. Mehnert A, Müller D, Lehmann C, Koch U. Die deutsche Version des NCCN Distress-Thermometers. Psychother Psychosom Med Psychol. 2006;54(3):213-223.
7. Bower JE. Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat Rev Clin Oncol. 2014;11(10):597-609.
8. van den Beuken-van Everdingen MHJ, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18(9):1437-1449.
9. Janelsins MC, Kesler SR, Ahles TA, Morrow GR. Prevalence, mechanisms, and management of cancer-related cognitive impairment. Int Rev Psychiatry. 2014;26(1):102-113.
10. Bayly JL, Lloyd-Williams M. Identifying functional impairment and rehabilitation needs in patients newly diagnosed with inoperable lung cancer: a structured literature review. Support Care Cancer. 2016;24(5):2359-2379.
11. Aaronson NK, Mattioli V, Minton O, et al. Beyond treatment—psychosocial and behavioural issues in cancer survivorship research and practice. Eur J Cancer Suppl. 2014;12(1):54-64.
12. Teunissen SCCM, de Graeff A, Voest EE, de Haes JCJM. Are anxiety and depressed mood related to physical symptom burden? A study in hospitalized advanced cancer patients. Palliat Med. 2007;21(4):341-346.
13. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30(3):208-225.
14. Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF. Leitlinienprogramm Onkologie: Psychoonkologische Diagnostik, Beratung und Behandlung von erwachsenen Krebspatienten, Langversion 1.1, 2014, AWMF-Registernummer: 032/051OL. http://leitlinienprogramm-onkologie.de/Leitlinien.7.0.html [accessed February 10, 2016].
15. National Comprehensive Cancer Network. Distress management. http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf [accessed February 10, 2016].
16. Meggiolaro E, Berardi MA, Andritsch E, et al. Cancer patients' emotional distress, coping styles and perception of doctor-patient interaction in European cancer settings. Palliat Support Care. 2015;1-8.
17. Han WT, Collie K, Koopman C, et al. Breast cancer and problems with medical interactions: relationships with traumatic stress, emotional self-efficacy, and social support. Psycho-Oncology. 2005;14(4):318-330.
18. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma. Cancer. 1998;82(10):1904-1908.
19. Lam WWT, Soong I, Yau TK, et al. The evolution of psychological distress trajectories in women diagnosed with advanced breast cancer: a longitudinal study. Psycho-Oncology. 2013;22(12):2831-2839.
20. Berry DL, Blonquist TM, Hong F, Halpenny B, Partridge AH. Self-reported adherence to oral cancer therapy: relationships with symptom distress, depression, and personal characteristics. Patient Prefer Adherence. 2015;9:1587-1592.
21. Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psycho-Oncology. 2011;20(5):463-469.
22. Giese-Davis J, Waller A, Carlson LE, et al. Screening for distress, the 6th vital sign: common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age. BMC Cancer. 2012;12:441.
23. Meijer A, Roseman M, Delisle VC, et al. Effects of screening for psychological distress on patient outcomes in cancer: a systematic review. J Psychosom Res. 2013;75(1):1-17.
24. Mitchell AJ. Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol. 2013;52(2):216-224.
25. Petty L, Lester J. Distress screening in chronic disease: essential for cancer survivors. J Adv Pract Oncol. 2014;5(2):107-114.
26. Acquati C, Kayser K. Predictors of psychological distress among cancer patients receiving care at a safety-net institution: the role of younger age and psychosocial problems. Support Care Cancer. 2017; https://doi.org/10.1007/s00520-017-3641-8
27. Admiraal JM, van Nuenen FM, Burgerhof JG, Reyners AK, Hoekstra-Weebers JE. Cancer patients' referral wish: effects of distress, problems, socio-demographic and illness-related variables and social support sufficiency. Psycho-Oncology. 2016;25(11):1363-1370.
28. Lo-Fo-Wong DN, de Haes HC, Aaronson NK, et al. Predictors of enduring clinical distress in women with breast cancer. Breast Cancer Res Treat. 2016;158(3):563-572.
29. VanHoose L, Black LL, Doty K, et al. An analysis of the DT problem list and distress in patients with cancer. Support Care Cancer. 2015;23(5):1225-1232.
30. Blenkiron P, Brooks A, Dearden R, McVey J. Use of the DT to evaluate symptoms, outcome and satisfaction in a specialist psycho-oncology service. Gen Hosp Psychiatry. 2014;36(6):607-612.
31. Mehnert A, Koch U, Schulz H, et al. Prevalence of mental disorders, psychosocial distress and need for psychosocial support in cancer patients-study protocol of an epidemiological multi-center study. BMC Psychiat. 2012;12:70
32. Mehnert A, Brähler E, Faller H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol. 2014;32(31):3540-3546.
33. Kuhnt S, Brähler E, Faller H, et al. Twelve-month and lifetime prevalence of mental disorders in cancer patients. Psychother Psychosom. 2016;85(5):289-296.
34. Donovan KA, Grassi L, McGinty HL, Jacobsen PB. Validation of the distress thermometer worldwide: state of the science. Psycho-Oncol. 2014;23(3):241-250. https://doi.org/10.1002/pon.3430
35. Kaufman L, Rousseeuw PJ. Finding Groups in Data: An Introduction to Cluster Analysis. Hoboken, N.J: Wiley; 2005.
36. Maechler M, Rousseeuw P, Struyf A, Hubert M, Hornik K, Studer M et al. Cluster: cluster analysis basics and extensions. R package version 2.0.2., 2015.
37. Clarke B, Fokoué E, Zhang HH. Principles and Theory for Data Mining and Machine Learning. Heidelberg: Springer; 2009.
38. Kendall J, Glaze K, Oakland S, Hansen J, Parry C. What do 1281 distress screeners tell us about cancer patients in a community cancer center? Psycho-Oncology. 2011;20(6):594-600.
39. Carlson LE, Groff SL, Maciejewski O, Bultz BD. Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol. 2010;28(33):4884-4891.
40. Carlson LE, Angen M, Cullum J, et al. High levels of untreated distress and fatigue in cancer patients. Br J Cancer. 2004;90(12):2297-2304. https://doi.org/10.1038/sj.bjc.6601887
41. Linden W, Vodermaier A, MacKenzie R, Greig D. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2-3):343-351.
42. Kurz K, Reißig A, Strauß B, Rosendahl J. Geschlechtsunterschiede in der psychischen Belastung von Patienten mit Lungenkarzinom und deren Partnern. Psychother Psychosom Med Psychol. 2014;64(11):431-438.
43. Jacobi F, Wittchen H, HÖLTING C, et al. Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med. 2004;34(4):597-611.
44. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627.
45. Eaton NR, Keyes KM, Krueger RF, et al. An invariant dimensional liability model of gender differences in mental disorder prevalence: evidence from a national sample. J Abnorm Psychol. 2012;121(1):282-288.
46. Gao W, Bennett MI, Stark D, Murray S, Higginson IJ. Psychological distress in cancer from survivorship to end of life care: prevalence, associated factors and clinical implications. Eur J Cancer. 2010;46(11):2036-2044.
47. Thoits PA. Gender differences in coping with emotional distress. In: Eckenrode J, ed. The Social Context of Coping. Boston, MA: Springer US; 1991:107-138.
48. Poort H, van der Graaf WT, Tielen R, et al. Prevalence, impact, and correlates of severe fatigue in patients with gastrointestinal stromal tumors. J Pain Symptom Manage. 2016;52(2):265-271.
49. Berger AM, Mitchell SA, Jacobsen PB, Pirl WF. Screening, evaluation, and management of cancer-related fatigue: ready for implementation to practice? CA Cancer J Clin. 2015;65(3):190-211.
50. Barsevick AM, Irwin MR, Hinds P, et al. Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst. 2013;105(19):1432-1440.
51. Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605-1619.
52. Boyes A, D'Este C, Carey M, Lecathelinais C, Girgis A. How does the distress thermometer compare to the Hospital Anxiety and Depression Scale for detecting possible cases of psychological morbidity among cancer survivors? Support Care Cancer. 2013;21(1):119-127.